The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.00
Bid: 56.00
Ask: 58.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.571%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 57.00
MAV4 Live PriceLast checked at -
Maven Income and Growth VCT 4 is an Investment Trust

To achieve long term capital appreciation and generate income by investing the majority of its funds in a diversified portfolio of shares and securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

17 May 2017 14:25

RNS Number : 4485F
Maven Income & Growth VCT 4 PLC
17 May 2017
 

 

Maven Income and Growth VCT 4 PLC

Result of Annual General Meeting

 

At the Annual General Meeting of the Company held at 10.30 am at Fifth Floor, 1-2 Royal Exchange Buildings, London, EC3V 3LF on 17 May 2017, all of the Resolutions put to the Meeting were duly passed.

 

At the record date for the Annual General Meeting, being 15 May 2017, the total number of voting rights in the Company stood at 32,767,502 Ordinary Shares. In accordance with the provisions of E.2.2 of the UK Corporate Governance Code, the Company advises that for the Annual General Meeting, valid proxy appointments were made in respect of 3,972,861 shares and that the number of proxy votes lodged for each Resolution were as follows:

 

Resolutions

For

Discretion

Against

Withheld

Total

1

To receive the Annual Report and audited Financial Statements.

3,854,111

104,885

0

13,865

3,972,861

2

To approve the Directors' Remuneration Report.

2,873,170

97,294

959,122

43,275

3,972,861

3

To approve the Directors' Remuneration Policy.

3,331,703

108,526

487,511

45,121

3,972,861

4

To approve a final dividend.

3,863,639

104,762

4,460

0

3,972,861

5

To re-elect Mr Cormack as a Director.

3,658,262

116,948

167,229

30,422

3,972,861

6

To re-elect Mr Graham-Wood as a Director.

3,654,209

122,020

166,210

30,422

3,972,861

7

To re-elect Mr Scott as a Director.

3,734,401

132,901

75,137

30,422

3,972,861

8

To re-elect Mr Nixon as a Director.

3,718,182

151,281

77,744

25,654

3,972,861

9

To re-appoint Deloitte LLP as Auditor.

3,420,186

160,474

380,571

11,630

3,972,861

10

To authorise the Directors to fix the remuneration of the Auditor.

3,794,009

141,724

17,998

19,130

3,972,861

11

To authorise the Directors to allot new shares.

3,787,895

131,600

22,735

30,631

3,972,861

12

To authorise disapplication of pre-emption rights.

3,627,875

131,600

125,146

88,240

3,972,861

13

To authorise the Company to purchase its own shares.

2,985,482

124,556

846,392

16,431

3,972,861

14

To allow a General Meeting to be called on not less than 14 days' notice.

3,446,170

387,084

117,313

22,294

3,972,861

 

The Board notes that Resolution 2, an Ordinary Resolution relating to the approval of the Directors' Remuneration Report, was duly passed but recognises that a significant minority of Shareholders have voted against the Resolution. It is intended that the Remuneration Committee will give this due consideration in its future deliberations

 

The Directors also note that Resolution 13, a Special Resolution relating to the buying back of shares, was duly passed, but once again recognise that a significant minority of Shareholders have voted against the Resolution. It is intended that the Board will consider the views expressed by Shareholders when it next seeks such an authority.

 

A vote withheld is not a vote in law and any such votes have not been included in the votes for or against the respective Resolutions. These proxy voting figures will also be available to view at: www.mavencp.com/migvct4.

 

 

 

 

Passing of Resolutions under Special Business

Copies of Resolutions passed under Special Business have been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.morningstar.co.uk/uk/NSM.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP, Secretary

17 May 2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGBXGDUXDBBGRR
Date   Source Headline
9th Nov 20223:02 pmRNSResult of General Meeting
7th Oct 20224:28 pmRNSPublication of a Prospectus
7th Oct 20229:58 amRNSDirector/PDMR Shareholding
7th Oct 20229:51 amRNSIssue of Equity
4th Oct 20223:30 pmRNSChange of Auditor
3rd Oct 20223:08 pmRNSStatement re Dividend Investment Scheme
6th Sep 20224:48 pmRNSTransaction in Own Shares
2nd Sep 20223:30 pmRNSHalf-year Report
19th Aug 202210:47 amRNSStatement re NAV and Interim Dividend
14th Jul 20229:33 amRNSDirectorate Change
8th Jul 20223:28 pmRNSStatement re Joint Offers for Subscription
24th Jun 20224:13 pmRNSDirectorate Change
9th Jun 20224:18 pmRNSTransaction in Own Shares
6th Jun 20222:15 pmRNSIssue of Equity
20th May 202210:09 amRNSDirector/PDMR Shareholding
20th May 202210:03 amRNSIssue of Equity
13th May 20223:24 pmRNSStatement re Dividend Investment Scheme
12th May 20223:19 pmRNSNet Asset Value(s)
11th May 20222:01 pmRNSResult of AGM & Directorate Change
26th Apr 202212:34 pmRNSIssue of Supplementary Prospectus
5th Apr 20226:30 pmRNSIssue of Equity
23rd Mar 20225:10 pmRNSDirector/PDMR Shareholding
23rd Mar 20225:05 pmRNSIssue of Equity
22nd Mar 20223:23 pmRNSAnnual Financial Report
16th Mar 20223:32 pmRNSTransaction in Own Shares
15th Mar 20223:09 pmRNSTransaction in Own Shares
11th Mar 202211:41 amRNSIssue of Equity - Dividend Investment Scheme
10th Mar 202211:30 amRNSIssue of Equity
10th Mar 202211:20 amRNSStatement re Dividend Investment Scheme
10th Mar 202211:04 amRNSNet Asset Value and Proposed Final Dividend
18th Feb 20225:32 pmRNSIssue of Equity - Replacement Announcement
7th Feb 202212:49 pmRNSDirector/PDMR Shareholding
7th Feb 202212:48 pmRNSDirector/PDMR Shareholding
7th Feb 202210:51 amRNSIssue of Equity
4th Feb 20229:46 amRNSNet Asset Value(s)
31st Jan 20224:25 pmRNSStatement re Offer for Suscription
10th Jan 202212:43 pmRNSStatement re Offer for Subscription
5th Jan 202210:35 amRNSDividend Declaration
2nd Dec 20213:37 pmRNSTransaction in Own Shares
11th Nov 20213:25 pmRNSNet Asset Value(s)
20th Oct 20214:44 pmRNSResult of General Meeting
1st Oct 20219:22 amRNSIssue of Equity
28th Sep 20213:22 pmRNSStatement re Dividend Investment Scheme
20th Sep 20215:42 pmRNSStatement re Change of Registrar
20th Sep 20215:21 pmRNSPublication of a Prospectus
7th Sep 20214:47 pmRNSTransaction in Own Shares
31st Aug 20213:27 pmRNSTransaction in Own Shares
27th Aug 20213:23 pmRNSHalf-year Report
24th Aug 20213:42 pmRNSTransaction in Own Shares
23rd Aug 20213:14 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.